| Market Cap | 18.36M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -143.28M | Forward P/E | -0.94 | EPS next Y | - | 50D Avg Chg | 26.00% |
| Sales | 212.13M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -62.00% |
| Dividend | N/A | Price/Book | 0.30 | EPS next 5Y | 9.80% | 52W High Chg | -90.00% |
| Recommedations | 3.00 | Quick Ratio | 0.72 | Shares Outstanding | 40.60M | 52W Low Chg | 319.00% |
| Insider Own | 10.13% | ROA | -41.80% | Shares Float | 30.26M | Beta | 3.76 |
| Inst Own | 23.90% | ROE | -112.43% | Shares Shorted/Prior | 676.85K/1.21M | Price | 0.45 |
| Gross Margin | -18.48% | Profit Margin | -67.54% | Avg. Volume | 21,451,802 | Target Price | 0.50 |
| Oper. Margin | -64.94% | Earnings Date | May 10 | Volume | 36,259,018 | Change | 0.00% |
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Engelson Erik T. | President and Chief.. President and Chief Executive | Mar 03 | Sell | 1.06 | 634,666 | 672,746 | 23,282 | 03/13/23 |
| Engelson Erik T. | President and Chief.. President and Chief Executive | Mar 03 | Option | 0.82 | 574,666 | 471,226 | 657,948 | 03/13/23 |
| Narido Richard Clavano | Chief Financial Offi.. Chief Financial Officer | Mar 03 | Sell | 0.85 | 29,383 | 24,976 | 77,910 | 03/13/23 |
| Collins Kevin Walter | Chief Revenue Office.. Chief Revenue Officer | Mar 03 | Sell | 0.82 | 111,819 | 91,692 | 234,903 | 03/13/23 |
| Allen Anthony Joseph | Chief Operations Off.. Chief Operations Officer | Mar 03 | Sell | 1.00 | 8,405 | 8,405 | 136,520 | 03/13/23 |
| Kashmolah Ghazi | Ex VP & Chief Qualit.. Ex VP & Chief Quality Officer | Feb 16 | Sell | 0.27 | 5,028 | 1,358 | 134,075 | 02/21/23 |
| Allen Anthony Joseph | Chief Operations Off.. Chief Operations Officer | Dec 20 | Sell | 0.16 | 4,263 | 682 | 144,925 | 12/22/22 |
| Collins Kevin Walter | Chief Revenue Office.. Chief Revenue Officer | Nov 27 | Sell | 0.42 | 9,666 | 4,060 | 346,722 | 11/29/22 |
| Kashmolah Ghazi | Ex VP & Chief Qualit.. Ex VP & Chief Quality Officer | Nov 16 | Sell | 0.35 | 4,790 | 1,676 | 179,887 | 11/18/22 |
| Engelson Erik T. | President and Chief.. President and Chief Executive | Sep 15 | Buy | 1.82 | 20,000 | 36,400 | 83,282 | 09/19/22 |
| Mitra Debkishore | Chief Technology Off.. Chief Technology Officer | Sep 01 | Sell | 1.694 | 191 | 324 | 382,208 | 09/06/22 |
| Collins Kevin Walter | Chief Revenue Office.. Chief Revenue Officer | Aug 27 | Sell | 1.72 | 8,580 | 14,758 | 356,388 | 08/29/22 |
| Kashmolah Ghazi | Ex VP & Chief Qualit.. Ex VP & Chief Quality Officer | Aug 25 | Sell | 1.93 | 1,500 | 2,895 | 184,677 | 08/29/22 |
| Kashmolah Ghazi | Ex VP & Chief Qualit.. Ex VP & Chief Quality Officer | Aug 17 | Sell | 2.52 | 19,074 | 48,066 | 180,757 | 08/24/22 |
| Mitra Debkishore | Chief Technology Off.. Chief Technology Officer | Mar 01 | Sell | 3.27 | 1,076 | 3,519 | 382,399 | 07/12/22 |
| Prashar Tamanna | Vice President Vice President | Mar 01 | Sell | 3.02 | 1,794 | 5,418 | 117,394 | 07/12/22 |
| Collins Kevin Walter | Chief Revenue Office.. Chief Revenue Officer | May 27 | Sell | 2.00 | 37,109 | 74,218 | 364,968 | 07/12/22 |
| George Dan | CFO and Treasurer CFO and Treasurer | Jun 18 | Sell | 1.45 | 1,321 | 1,915 | 46,354 | 07/12/22 |
| Engelson Erik T. | President and Chief.. President and Chief Executive | Jun 16 | Buy | 1.49 | 10,000 | 14,900 | 63,282 | 06/17/22 |
| Engelson Erik T. | President and Chief.. President and Chief Executive | Mar 15 | Buy | 3.00 | 30,000 | 90,000 | 53,282 | 03/16/22 |